Oct 10
|
Conference Call on Interim Report
|
Aug 16
|
Results From European Randomized Controlled Study Using XVIVO's Heart Technology Published in The Lancet
|
Jun 25
|
Swedish Exchange Highlights: Lime Technologies And Two More Stocks Seemingly Priced Below Estimated True Value
|
Jan 12
|
Conference Call on Report on Operations 2023
|
Dec 22
|
XVIVO Reaches Milestone in Italy: 1,200 Lifesaving Perfusions Performed with Liver Assist
|
May 23
|
Patient Inclusion Completed in European Clinical Trial with XVIVO's Heart Preservation Technology
|